Search research articles
Contact Us
Filters
Showing results (21-30 of 109) with videos related to
Page
of 11
Sort By:
Scientific Reports
|
May 14, 2021
Systematic review and meta-analysis for prevention of cardiovascular complications using GLP-1 receptor agonists and SGLT-2 inhibitors in obese diabetic patients
Kazushi Uneda, Yuki Kawai, Takayuki Yamada, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension
|
September 5, 2014
Therapeutic impact of the single fixed-dose combination with a high-dose angiotensin-receptor blocker and a low-dose thiazide diuretic in the management of hypertension: awaiting further accumulation of clinical evidence
Kouichi Tamura, Koji Ohki, Ryu Kobayashi, et al.
Diabetes Research and Clinical Practice
|
November 20, 2022
Cardiovascular and kidney outcomes of combination therapy with sodium-glucose cotransporter-2 inhibitors and mineralocorticoid receptor antagonists in patients with type 2 diabetes and chronic kidney disease: A systematic review and network meta-analysis
Shunichiro Tsukamoto, Ryutaro Morita, Takayuki Yamada, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension
|
November 17, 2012
The angiotensin II type 1 receptor blocker olmesartan preferentially improves nocturnal hypertension and proteinuria in chronic kidney disease
Mai Yanagi, Kouichi Tamura, Tetsuya Fujikawa, et al.
Clinical Rheumatology
|
October 13, 2021
Prevention of kidney function decline using uric acid-lowering therapy in chronic kidney disease patients: a systematic review and network meta-analysis
Shunichiro Tsukamoto, Naohito Okami, Takayuki Yamada, et al.
The Journal of Biological Chemistry
|
November 19, 2023
miR-125a-5p/miR-125b-5p contributes to pathological activation of angiotensin II-AT1R in mouse distal convoluted tubule cells by the suppression of Atrap
Keigo Hirota, Akio Yamashita, Eriko Abe, et al.
International Journal of Molecular Sciences
|
January 11, 2022
Blood Pressure Elevation of Tubular Specific (P)RR Transgenic Mice and Lethal Tubular Degeneration due to Possible Intracellular Interactions between (P)RR and Alternative Renin Products
Sae Saigo, Tabito Kino, Kotaro Uchida, et al.
Frontiers in Pharmacology
|
June 6, 2022
Comparative Efficacy of Pharmacological Treatments for Adults With Autosomal Dominant Polycystic Kidney Disease: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials
Shunichiro Tsukamoto, Shingo Urate, Takayuki Yamada, et al.
Diabetes Research and Clinical Practice
|
November 15, 2021
Comparison of effects of SGLT-2 inhibitors and GLP-1 receptor agonists on cardiovascular and renal outcomes in type 2 diabetes mellitus patients with/without albuminuria: A systematic review and network meta-analysis
Yuki Kawai, Kazushi Uneda, Takayuki Yamada, et al.
CEN Case Reports
|
July 30, 2024
Behcet's disease presenting as malignant hypertension induced by renovascular hypertension
Sho Kinguchi, Misumi Tamura, Rika Furuta, et al.
Page
of 11
Search research articles
Search
Showing results (21-30 of 109) with videos related to
Sort By:
Page
of 11
Scientific Reports
|
May 14, 2021
Systematic review and meta-analysis for prevention of cardiovascular complications using GLP-1 receptor agonists and SGLT-2 inhibitors in obese diabetic patients
Kazushi Uneda, Yuki Kawai, Takayuki Yamada, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension
|
September 5, 2014
Therapeutic impact of the single fixed-dose combination with a high-dose angiotensin-receptor blocker and a low-dose thiazide diuretic in the management of hypertension: awaiting further accumulation of clinical evidence
Kouichi Tamura, Koji Ohki, Ryu Kobayashi, et al.
Diabetes Research and Clinical Practice
|
November 20, 2022
Cardiovascular and kidney outcomes of combination therapy with sodium-glucose cotransporter-2 inhibitors and mineralocorticoid receptor antagonists in patients with type 2 diabetes and chronic kidney disease: A systematic review and network meta-analysis
Shunichiro Tsukamoto, Ryutaro Morita, Takayuki Yamada, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension
|
November 17, 2012
The angiotensin II type 1 receptor blocker olmesartan preferentially improves nocturnal hypertension and proteinuria in chronic kidney disease
Mai Yanagi, Kouichi Tamura, Tetsuya Fujikawa, et al.
Clinical Rheumatology
|
October 13, 2021
Prevention of kidney function decline using uric acid-lowering therapy in chronic kidney disease patients: a systematic review and network meta-analysis
Shunichiro Tsukamoto, Naohito Okami, Takayuki Yamada, et al.
The Journal of Biological Chemistry
|
November 19, 2023
miR-125a-5p/miR-125b-5p contributes to pathological activation of angiotensin II-AT1R in mouse distal convoluted tubule cells by the suppression of Atrap
Keigo Hirota, Akio Yamashita, Eriko Abe, et al.
International Journal of Molecular Sciences
|
January 11, 2022
Blood Pressure Elevation of Tubular Specific (P)RR Transgenic Mice and Lethal Tubular Degeneration due to Possible Intracellular Interactions between (P)RR and Alternative Renin Products
Sae Saigo, Tabito Kino, Kotaro Uchida, et al.
Frontiers in Pharmacology
|
June 6, 2022
Comparative Efficacy of Pharmacological Treatments for Adults With Autosomal Dominant Polycystic Kidney Disease: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials
Shunichiro Tsukamoto, Shingo Urate, Takayuki Yamada, et al.
Diabetes Research and Clinical Practice
|
November 15, 2021
Comparison of effects of SGLT-2 inhibitors and GLP-1 receptor agonists on cardiovascular and renal outcomes in type 2 diabetes mellitus patients with/without albuminuria: A systematic review and network meta-analysis
Yuki Kawai, Kazushi Uneda, Takayuki Yamada, et al.
CEN Case Reports
|
July 30, 2024
Behcet's disease presenting as malignant hypertension induced by renovascular hypertension
Sho Kinguchi, Misumi Tamura, Rika Furuta, et al.
Page
of 11